+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Erectile Dysfunction Global Clinical Trials Review, H1, 2020

  • ID: 4987505
  • Clinical Trials
  • January 2020
  • Region: Global
  • 477 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • Dong-A Socio Group
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Hanmi Science Co Ltd
  • MORE
Erectile Dysfunction Global Clinical Trials Review, H1, 2020

Summary

The clinical trial report, “Erectile Dysfunction Global Clinical Trials Review, H1, 2020' provides an overview of Erectile Dysfunction Clinical trials scenario. This report provides top line data relating to the clinical trials on Erectile Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • Dong-A Socio Group
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Hanmi Science Co Ltd
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Erectile Dysfunction to Male Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Erectile Dysfunction to Male Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Erectile Dysfunction Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Erectile Dysfunction
  • Oct 28, 2019: New clinical data provide additional validation for the safety and efficacy of Futura Medical’s topical MED2005 in the treatment of erectile dysfunction
  • Oct 21, 2019: Final dosing of last patient in MED2005 phase 3 study
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Author
  • Contact Us
  • Source
List of Tables
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials by Region, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Erectile Dysfunction to Male Health Clinical Trials, G7 Countries (%), 2020*
  • Erectile Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Erectile Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Erectile Dysfunction to Male Health Clinical Trials, E7 Countries (%), 2020*
  • Erectile Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Erectile Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Erectile Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
List of Figures
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Erectile Dysfunction to Male Health Clinical Trials, G7 Countries (%), 2020*
  • Erectile Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Erectile Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Erectile Dysfunction to Male Health Clinical Trials, E7 Countries (%), 2020*
  • Erectile Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Erectile Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Erectile Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Erectile Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Erectile Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Eli Lilly and Co
  • Bayer AG
  • Pfizer Inc
  • Seelos Therapeutics, Inc.
  • Vivus Inc
  • GlaxoSmithKline Plc
  • Hanmi Science Co Ltd
  • SK Chemicals Co Ltd
  • Allergan Plc
  • Dong-A Socio Group
Note: Product cover images may vary from those shown
Adroll
adroll